Tofacitinib suppresses disease activity and febrile attacks in a patient with coexisting rheumatoid arthritis and familial Mediterranean fever

Tofacitinib suppresses disease activity and febrile attacks in a patient with coexisting rheumatoid arthritis and familial Mediterranean fever

Familial Mediterranean fever (FMF) is the most common hereditary auto-inflammatory (periodic fever) syndrome, and usually successfully treated with colchicine. However, nearly 5-10% of FMF cases are resistant or intolerant to colchicine and treatment options are highly restricted in these cases. Bio...

Full description

Bibliographic Details
Main Authors: Kevser Gök, Gizem Cengiz, Kemal Erol, Salih Ozgocmen
Format: Article
Language:English
Published: Sociedade Portuguesa de Reumatologia 2017-01-01
Series:Acta Reumatológica Portuguesa
Subjects:
familial mediterranean fever
treatment
biological agents
Online Access:http://www.actareumatologica.com/files/article/1160_tofacitinib_suppresses_disease_activity_and_febrile_attacks_in_a_patient_with_coexisting_rheumatoid_arthritis_and_familial_mediterranean_fever_file.pdf

Internet

http://www.actareumatologica.com/files/article/1160_tofacitinib_suppresses_disease_activity_and_febrile_attacks_in_a_patient_with_coexisting_rheumatoid_arthritis_and_familial_mediterranean_fever_file.pdf

Similar Items